Influence of glucose metabolism on vascular smooth muscle cell proliferation

Vasa - Journal of Vascular Diseases

Volumn 42, Issue 1, 2013, Pages 8-16

  Chiong, Mario ^a   Morales, Pablo Esteban ^a   Torres, Gloria ^a   Gutiérrez, Tomás ^a   García, Lorena ^a   Ibacache, Mauricio ^a   Michea, Luis ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Glucose metabolism; Mitochondrial bioenergetics; Proliferation; Vascular smooth muscle cells

Indexed keywords

GLUCOSE TRANSPORTER 1; GUANOSINE TRIPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOFUSIN 2; SOMATOMEDIN C RECEPTOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SOMATOMEDIN C; TARGET OF RAPAMYCIN KINASE;

CELL PROLIFERATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; INTRACELLULAR SIGNALING; MITOCHONDRIAL ENERGY TRANSFER; REVIEW; VASCULAR SMOOTH MUSCLE; ANIMAL; ATHEROSCLEROSIS; HYPERPLASIA; METABOLISM; MUSCLE MITOCHONDRION; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ATHEROSCLEROSIS; CELL PROLIFERATION; ENERGY METABOLISM; GLUCOSE; HUMANS; HYPERPLASIA; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MITOCHONDRIA, MUSCLE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

MLCS; MLOWN;

EID: 84877050233     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000243     Document Type: Review

References (56)

1. Adhikari N, Basi DL, Carlson M, Mariash A, Hong Z, Lehman U, Mullegama S, Weir EK, Hall JL. Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury. Arterioscler Thromb Vasc Biol 2011; 31: 86 - 94.
2. Banz WJ, Abel MA, Zemel MB. Insulin regulation of vascular smooth muscle glucose transport in insulin-sensitive and resistant rats. Horm Metab Res 1996; 28: 271 - 275.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570 - 2581.
4. Bergandi L, Silvagno F, Russo I, Riganti C, Anfossi G, Aldieri E, Ghigo D, Trovati M, Bosia A. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23: 2215 - 2221.
5. Bessman SP, Geiger PJ. Transport of energy in muscle: the phosphorylcreatine shuttle. Science 1981; 211: 448 - 452.
6. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989; 38: 504 - 509.
7. Bravo R, Vicencio JM, Parra V, Troncoso R, Munoz JP, Bui M, Quiroga C, Rodriguez AE, Verdejo HE, Ferreira J, Iglewski M, Chiong M, Simmen T, Zorzano A, Hill JA, Rothermel BA, Szabadkai G, Lavandero S. Increased ERmitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci 2011; 124: 2143 - 2152.
8. Buller CL, Loberg RD, Fan MH, Zhu Q, Park JL, Vesely E, Inoki K, Guan KL, Brosius FC, 3rd. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol 2008; 295: C836 - 843.
9. Butler TM, Siegman MJ. Highenergy phosphate metabolism in vascular smooth muscle. Annu Rev Physiol 1985; 47: 629 - 643.
10. Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985; 42: 139 - 162.
11. Cecchettini A, Rocchiccioli S, Boccardi C, Citti L. Vascular smoothmuscle-cell activation: proteomics point of view. Int Rev Cell Mol Biol 2011; 288: 43 - 99.
12. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 2004; 6: 872 - 883.
13. Gayard M, Guilluy C, Rousselle A, Viollet B, Henrion D, Pacaud P, Loirand G, Rolli-Derkinderen M. AMPK alpha 1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol. Arterioscler Thromb Vasc Biol 2011; 31: 2634 - 2642.
14. Guo X, Chen KH, Guo Y, Liao H, Tang J, Xiao RP. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res 2007; 101: 1113 - 1122.
15. Guo YH, Chen K, Gao W, Li Q, Chen L, Wang GS, Tang J. Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun 2007; 363: 411 - 417.
16. Hall JL, Chatham JC, Eldar-Finkelman H, Gibbons GH. Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta. Diabetes 2001; 50: 1171 - 1179.
17. Hellstrand P, Jorup C, Lydrup ML. O2 consumption, aerobic glycolysis and tissue phosphagen content during activation of the Na+/K+ pump in rat portal vein. Pflugers Arch 1984; 401: 119 - 124.
18. Hiroishi G, Kobayashi S, Nishimura J, Inomata H, Kanaide H. High D-glucose stimulates the cell cycle from the G1 to the S and M phases, but has no competent effect on the G0 phase, in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 211: 619 - 626.
19. Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D, Matsumoto K, Toyonaga T, Asano T, Nishikawa T, Araki E. Adenosine monophosphate-activated protein kinase sup presses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res 2005; 97: 837 - 844.
20. Johansson GS, Arnqvist HJ. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 2006; 291: E1124 - 1130.
21. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510 - 2516.
22. Kang WC, Park YM, Shin KC, Moon CI, Lee K, Han SH, Shin MS, Moon J, Ahn T, Shin EK. Comparison of edge vascular response after sirolimus-and paclitaxel-eluting stent implantation. Int J Cardiol 2011;
23. Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 1994; 8: 43 - 53.
24. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997; 95: 1366 - 1369.
25. Krymskaya VP, Snow J, Cesarone G, Khavin I, Goncharov DA, Lim PN, Veasey SC, Ihida-Stansbury K, Jones PL, Goncharova EA. mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia. FASEB J 2011; 25: 1922 - 1933.
26. Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci 2009; 122: 3589 - 3594.
27. Lund DD, Faraci FM, Miller FJ, Jr., Heistad DD. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 2000; 101: 1027 - 1033.
28. Lynch RM, Paul RJ. Compartmentation of glycolytic and glycogenolytic metabolism in vascular smooth muscle. Science 1983; 222: 1344 - 1346.
29. Madi HA, Riches K, Warburton P, O'Regan DJ, Turner NA, Porter KE. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. Am J Physiol Cell Physiol 2009; 297: C1307 - 1317.
30. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR. Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology 2007; 148: 2435 - 2443.
31. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto K, Michelakis ED. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 2004; 95: 830 - 840.
32. Michelakis ED, Hampl V, Nsair A, Wu X, Harry G, Haromy A, Gurtu R, Archer SL. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 2002; 90: 1307 - 1315.
33. Muniyappa R, Quon MJ. Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care 2007; 10: 523 - 530.
34. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 2004; 110: 444 - 451.
35. Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 1992; 187: 552 - 560.
36. Paul RJ. Functional compartmentalization of oxidative and glycolytic metabolism in vascular smooth muscle. Am J Physiol Cell Physiol 1983; 244: C399 - 409.
37. Peyton KJ, Yu Y, Yates B, Shebib AR, Liu XM, Wang H, Durante W. Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion. J Pharmacol Exp Ther 2011; 338: 476 - 484.
38. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98: 2277 - 2283.
39. Radhakrishnan Y, Busby WH, Jr., Shen X, Maile LA, Clemmons DR. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing proteintyrosine phosphatase substrate-1 function in vascular smooth muscle cells. J Biol Chem 2010; 285: 15682 - 15695.
40. Radhakrishnan Y, Maile LA, Ling Y, Graves LM, Clemmons DR. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. J Biol Chem 2008; 283: 16320 - 16331.
41. Ramana KV, Bhatnagar A, Srivastava S, Yadav UC, Awasthi S, Awasthi YC, Srivastava SK. Mitogenic responses of vascular smooth muscle cells to lipid peroxidationderived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem 2006; 281: 17652 - 17660.
42. Rubin LJ, Magliola L, Feng X, Jones AW, Hale CC. Metabolic activation of AMP kinase in vascular smooth muscle. J Appl Physiol 2005; 98: 296 - 306.
43. Ruiz-Torres A, Lozano R, Melon J, Carraro R. On how insulin may influence ageing and become atherogenic throughout the insulin-like growth factor-1 receptor pathway: in vitro studies with human vascular smooth muscle cells. Gerontology 2005; 51: 225 - 230.
44. Ruiz E, Redondo S, Gordillo-Moscoso A, Tejerina T. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway. J Pharmacol Exp Ther 2007; 321: 431 - 438.
45. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 2007; 45 Suppl A: A25 - 32.
46. Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev 2009; 89: 1025 - 1078.
47. Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. Circulation 2001; 103: 2967 - 2972.
48. Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, Lopaschuk GD, Dyck JR, Michelakis ED. Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med 2010; 2: 44-58.
49. Sutendra G, Dromparis P, Wright P, Bonnet S, Haromy A, Hao Z, Mc-Murtry MS, Michalak M, Vance JE, Sessa WC, Michelakis ED. The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension. Sci Transl Med 2011; 3: 88-55.
50. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 2001; 50: 851 - 860.
51. Tammali R, Saxena A, Srivastava SK, Ramana KV. Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. Endocrinology 2010; 151: 2140 - 2150.
52. Testa L, Latini RA, Pizzocri S, Lanotte S, Agnifili M, Laudisa ML, Brambilla N, Bedogni F. Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis. Q J M 2011; 104: 1025 - 1034.
53. Vesely ED, Heilig CW, Brosius FC, 3rd. GLUT1-induced cFLIP expression promotes proliferation and prevents apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 2009; 297: C759 - 765.
54. Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 2004; 53: 2735 - 2740.
55. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with noninsulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567 - 574.
56. Zhou W, Chen KH, Cao W, Zeng J, Liao H, Zhao L, Guo X. Mutation of the protein kinase A phosphorylation site influences the anti-proliferative activity of mitofusin 2. Atherosclerosis 2010; 211: 216 - 223.